BloodPAC Data Common: Accelerating Data Sharing & Analysis

Time: 2:45 pm
day: Day One


• Exploring the BloodPAC Data Common and its applications in liquid biopsy-based studies

• Heading for approval: Demostrating how having an FDA approved Data Common positively impacts your future studies

• Looking ahead to future directions and applications of the project